Poly Medicure Limited has granted 17,500 stock options to eligible employees under its Employee Stock Option Scheme 2020. The grant was approved by the company's Nomination and Remuneration Committee during a meeting held on May 23, 2026.

The options have been issued at a price of INR 100 per share, which represents a discounted price relative to the latest available closing price on the stock exchange as of the grant date. Each option entitles the holder to convert it into one equity share of the company, subject to the terms of the scheme.

Vesting and Exercise Terms

The options are subject to a vesting schedule that prohibits vesting for a period of one year from the date of the grant. Upon the expiry of this one-year period, the vesting of options will occur over a maximum term of four years as per the scheme's provisions.

Once vested, the options must be exercised within a period of three months from the relevant vesting date. The Nomination and Remuneration Committee retains the authority to extend this period in exceptional circumstances. If not exercised within the stipulated time, the options will lapse.

Scheme Details

The scheme is administered by the Nomination and Remuneration Committee and is compliant with the SEBI (Share Based Employee Benefits) Regulations, 2021. The eligibility criteria for the grant of options are outlined in the scheme documents.

The grant of these options is intended to align the interests of employees with those of the shareholders and to incentivize long-term performance within the organization.

Poly Medicure Limited has scheduled a series of one-on-one meetings with analysts and investors commencing May 26, 2026. The company officials will engage with four major entities over four days, adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meetings will be conducted in physical format across two locations. The Registered Office in New Delhi will host two sessions, while the company's Plant in Faridabad will accommodate the remaining interactions. The company has explicitly stated that no unpublished price sensitive information will be shared during these discussions.

Schedule of Meetings

The following table outlines the detailed schedule for the investor meets:

The company noted that the above schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company itself. Further details regarding the meetings are available on the official website of poly medicure .